In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low ...

By Vijay Kumar Malesu New research reveals how hypoxia-driven red blood cell adaptations may reshape glucose regulation, offering fresh insight into diabetes biology and potential therapeutic ...

From thorn, seat, shout and stew to Bruno Mars and Bette Midler, test your knowledge with the Saturday quiz ...

In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low oxygen levels—such as those found at high altitudes. One of the most striking ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are ...

Researchers aimed at clarifying the mechanism underlying this connection and tracking the fate of glucose in hypoxic animals.

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...

Disc Medicine stock is hit by an FDA CRL for bitopertin. Learn key trial risks, cash runway, and why APOLLO Phase 3 results in 4Q26 matter.

US FDA approves AstraZeneca’s Calquence plus venetoclax as first all-oral, fixed-duration combination for patients with CLL in the 1st-line setting: Cambridge, UK Monday, Februa ...

Weight loss is often related to the colorectal cancer symptoms that can make it hard to eat, like diarrhea, stomach pain, or ...

Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates ...